Commerzbank Aktiengesellschaft FI Acquires 208 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Commerzbank Aktiengesellschaft FI raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 54,895 shares of the healthcare conglomerate’s stock after purchasing an additional 208 shares during the period. UnitedHealth Group accounts for approximately 0.9% of Commerzbank Aktiengesellschaft FI’s investment portfolio, making the stock its 29th biggest position. Commerzbank Aktiengesellschaft FI’s holdings in UnitedHealth Group were worth $32,096,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 0.6% during the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after acquiring an additional 94,641 shares in the last quarter. Bank of New York Mellon Corp raised its stake in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after purchasing an additional 35,533 shares in the last quarter. Dimensional Fund Advisors LP raised its position in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after buying an additional 21,149 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on UNH shares. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their target price for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Up 0.1 %

Shares of NYSE UNH opened at $570.56 on Wednesday. The stock has a market capitalization of $526.87 billion, a P/E ratio of 37.13, a P/E/G ratio of 1.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a 50-day moving average price of $584.46 and a 200-day moving average price of $536.30.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the business posted $6.56 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.